NO20070983L - Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav - Google Patents

Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav

Info

Publication number
NO20070983L
NO20070983L NO20070983A NO20070983A NO20070983L NO 20070983 L NO20070983 L NO 20070983L NO 20070983 A NO20070983 A NO 20070983A NO 20070983 A NO20070983 A NO 20070983A NO 20070983 L NO20070983 L NO 20070983L
Authority
NO
Norway
Prior art keywords
analogs
alpha
salts
tocopheryl succinate
stable injectable
Prior art date
Application number
NO20070983A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew Xian Chen
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Publication of NO20070983L publication Critical patent/NO20070983L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20070983A 2004-07-28 2007-02-21 Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav NO20070983L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59209704P 2004-07-28 2004-07-28
PCT/US2005/026783 WO2006015120A2 (en) 2004-07-28 2005-07-28 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof

Publications (1)

Publication Number Publication Date
NO20070983L true NO20070983L (no) 2007-02-27

Family

ID=35787824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070983A NO20070983L (no) 2004-07-28 2007-02-21 Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav

Country Status (11)

Country Link
US (1) US20060024360A1 (enExample)
EP (1) EP1778217A4 (enExample)
JP (1) JP2008508302A (enExample)
KR (1) KR20070059072A (enExample)
CN (1) CN1925853B (enExample)
AU (1) AU2005269383A1 (enExample)
CA (1) CA2575216A1 (enExample)
IL (1) IL180741A0 (enExample)
NO (1) NO20070983L (enExample)
RU (1) RU2007107359A (enExample)
WO (1) WO2006015120A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
US20080045589A1 (en) * 2006-05-26 2008-02-21 Susan Kelley Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
CA2663474C (en) 2006-09-15 2017-06-27 Griffith University Pro-oxidant anti-cancer compounds
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
CN101677987A (zh) * 2007-06-22 2010-03-24 赛多斯有限责任公司 不含吐温80的多西他赛的增溶制剂
KR101642157B1 (ko) 2008-03-14 2016-07-22 스티븐 존 랄프 미토콘드리아로 전달되는 항암 화합물
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
WO2011004552A1 (ja) * 2009-07-09 2011-01-13 国立大学法人九州大学 水溶性薬物キャリア及びその製造方法
US20110213025A1 (en) * 2009-08-10 2011-09-01 Proviflo, Llc Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids
WO2011025771A1 (en) * 2009-08-25 2011-03-03 Biogen Idec Ma Inc. Compositions for delivery of insoluble agents
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
US8541465B2 (en) * 2009-10-19 2013-09-24 Scidose, Llc Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
US8476310B2 (en) 2009-10-19 2013-07-02 Scidose Llc Docetaxel formulations with lipoic acid
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US20110092579A1 (en) * 2009-10-19 2011-04-21 Scidose Llc Solubilized formulation of docetaxel
UA110383C2 (en) 2011-06-08 2015-12-25 Akzo Nobel Chemicals Int Bv Deicing composition
CN103582686B (zh) 2011-06-08 2016-03-23 阿克佐诺贝尔化学国际公司 防冻组合物
AR088524A1 (es) 2011-11-09 2014-06-18 Akzo Nobel Chemicals Int Bv Composicion descongelante, proceso de preparacion, conjunto de parte y uso
CN104427977B (zh) 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
JP6087769B2 (ja) * 2013-08-30 2017-03-01 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods
PH12022550592A1 (en) * 2016-01-07 2023-07-17 Tesorx Pharma Llc Formulations for treating bladder cancer
US20200138855A1 (en) * 2017-07-20 2020-05-07 Delta-Fly Pharma, Inc. Novel antineoplastic drug based on specificity of cancer-cell metabolism
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
CN120365238A (zh) * 2025-05-29 2025-07-25 无锡知妍生物科技有限公司 单生育酚壬二酸酯及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173838A (en) * 1962-03-28 1965-03-16 Eastman Kodak Co Solid, vitamin e-active product and process for making it
US4783220A (en) * 1986-12-18 1988-11-08 Xerox Corporation Vesicle ink compositions
AU675930B2 (en) * 1992-02-18 1997-02-27 Pharmos Corp. Dry compositions for preparing submicron emulsions
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030005407A1 (en) * 2000-06-23 2003-01-02 Hines Kenneth J. System and method for coordination-centric design of software systems
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
US20040175415A1 (en) * 2003-03-05 2004-09-09 Chan Alvin C. Formulations and methods of delivery of intact tocopheryl succinate to humans
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Also Published As

Publication number Publication date
CA2575216A1 (en) 2006-02-09
RU2007107359A (ru) 2008-09-10
AU2005269383A1 (en) 2006-02-09
EP1778217A4 (en) 2008-10-08
KR20070059072A (ko) 2007-06-11
EP1778217A2 (en) 2007-05-02
WO2006015120A3 (en) 2006-05-18
CN1925853B (zh) 2011-01-26
US20060024360A1 (en) 2006-02-02
IL180741A0 (en) 2007-07-04
CN1925853A (zh) 2007-03-07
WO2006015120A2 (en) 2006-02-09
JP2008508302A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
WO2006015120A3 (en) Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof
NO20090596L (no) Antivirale fosfinatforbindelser
WO2018136202A3 (en) Compounds and methods for cdk8 modulation and indications therefor
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
CY1114539T1 (el) Η χρησιμοτητα των ιμιδαζοπυριδαζινοκαρβονιτριλιων ως αναστολεων κινασων
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
ATE433447T1 (de) Pyrimiidinverbindungen
NO20055590L (no) Kinaseinhiberende fosfonatanaloger
ECSP099357A (es) COMPUESTOS QUE MODULAN ACTIVIDAD C-FMS y/o C-KIT Y USOS PARA ELLO
SE0301010D0 (sv) Novel compounds
DOP2010000396A (es) Derivado de uracilo o timina para el tratamiento de hepatitis c
NO20085183L (no) Stabiliserte insulinlignende vekstfaktorpolypeptider
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
CY1113594T1 (el) Φουμαρικο αλας της (αλφα s, βητα r)-6-βρωμο-αλφα-[2-(διμεθυλαμινο)αιθυλ]-2-μεθοξυ-αλφα-1-ναφθαλινυλ-βητα-φαινυλ-3-κινολινοαιθανολης
NO20080391L (no) Pyrazolbaserte LXR modulatorer
TN2009000163A1 (en) Compounds and compositions as protein kinase inibitors
NO20090295L (no) Substituerte heteroarylderivater
ATE389662T1 (de) Cardioprotektive phosphonate
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
WO2008002571A3 (en) Human protein tyrosine phosphatase inhibitors and methods of use
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20083246L (no) Nye benzimidazolderivater som vanilloid-reseptor 1 (VRL) inhibitorer
ECSP056072A (es) Pirimidinonas sustituidas
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
DK1791830T3 (da) Diaminotriazol-forbindelser der er nyttige som protein-kinase-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application